Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: A pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD)

European Respiratory Journal

Volumn 8, Issue 9, 1995, Pages 1506-1513

  Maesen, F P V ^a   Smeets, J J ^a   Sledsens, T J H ^a   Wald, F D M ^a   Cornelissen, P J G ^a  

^a ATRIUM MEDICAL CENTER   (Netherlands)

Author keywords

antimuscarinic bronchodilator; chronic obstructive pulmonary disease; ipratropium bromide; long acting bronchodilators; tiotropium bromide

Indexed keywords

MUSCARINIC RECEPTOR BLOCKING AGENT; NEW DRUG; PLACEBO; TIOTROPIUM BROMIDE;

ADULT; AGED; ARTICLE; BRONCHODILATING ACTIVITY; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG SAFETY; FEMALE; HUMAN; INHALATIONAL DRUG ADMINISTRATION; LUNG FUNCTION; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; AGED; BRONCHODILATOR AGENTS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG DISEASES, OBSTRUCTIVE; MALE; MIDDLE AGED; SCOPOLAMINE DERIVATIVES; TIME FACTORS; TREATMENT OUTCOME;

EID: 0028886394     PISSN: 09031936     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)